Prostatic acid phosphatase by radioimmunoassay tumor marker in bone marrow.
Bone marrow acid phosphatase was determined by radioimmunoassay and enzymatic analysis in 95 patients with benign prostatic hypertrophy, 50 patients with disseminated prostatic carcinoma and 36 patients with non-prostatic malignancy. The results indicate superior specificity of the radioimmunoassay. A brief review of the topic and the clinical implications are discussed.
D000135:Acid Phosphatase / Q000378:metabolism*; D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000201:enzymology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000201:enzymology*; D011863:Radioimmunoassay
D000135:Acid Phosphatase